Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (10)
  • Microtubule Associated
    (7)
  • Kinesin
    (3)
  • PLK
    (3)
  • Akt
    (2)
  • Aurora Kinase
    (2)
  • FLT
    (2)
  • PDGFR
    (2)
  • VEGFR
    (2)
  • Others
    (35)
Filter
Search Result
Results for "

mitosis

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    66
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Peptide Products
    4
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    1
    TargetMol | Dye_Reagents
  • PROTAC Products
    3
    TargetMol | PROTAC
  • Natural Products
    8
    TargetMol | Natural_Products
  • Recombinant Protein
    39
    TargetMol | Recombinant_Protein
Mertansine
Maytansinoid DM1, DM1
T1992139504-50-0
Mertansine is a tubulin inhibitor and an antibody-conjugable maytansinoid alkaloid. The IC50 of Mertansine against HCT-15 and A431 cells is 0.750 and 0.04nM.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
Histone H3 (21-44)-GK-biotin amide (trifluoroacetate salt)
Histone H3 (21-44)-GK-biotin amide (trifluoroacetate salt)
T36979
Histone H3 (21-44)-GK-biotin is a peptide fragment of histone H3 that corresponds to amino acid residues 22-45 of the human histone H3.3 sequence and is biotinylated via a C-terminal GK linker. Unlike histone H3.1 and H3.2, the histone H3.3 variant contains a serine residue at position 31 that is phosphorylated during late prometaphase and metaphase of mitosis. Histone H3 (21-44) also contains lysine residues at positions 23, 27, and 36 that are subject to methylation and acetylation, all of which have a role in the regulation of gene expression, and a serine residue at position 28 that is subject to phosphorylation during mitosis.
  • Inquiry Price
Size
QTY
MMAE-SMCC
T183612021179-11-1
MMAE-SMCC is a drug-linker conjugate designed for antibody-drug conjugates (ADC). It consists of MMAE, a potent inhibitor of mitosis and tubulin, and SMCC, a linker that facilitates the development of ADCs.
  • Inquiry Price
Size
QTY